查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1966211

全球生物製藥輔料市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Biopharmaceutical Excipients Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計生物製藥輔料市場將從 2025 年的 81 億美元成長到 2034 年的 134.1 億美元，2026 年至 2034 年的複合年成長率為 5.76%。

受生物製藥和生物相似藥研發擴張的推動，全球生物製藥輔料市場正顯著成長。輔料在穩定、保存和提高生物製藥的遞送效率方面發揮著至關重要的作用。慢性病發病率的上升和對標靶治療需求的成長正在推動生技藥品的創新。不斷擴大的藥物研發和生產活動也進一步促進了市場成長。

關鍵促進因素包括蛋白質療法的進步、生技藥品監管核准的增加以及對提高藥物穩定性的需求。生物製藥輔料有助於在儲存和運輸過程中維持產品的療效。疫苗研發項目和單株抗體生產的擴展也促進了需求的成長。製藥公司與輔料生產商之間的合作正在加速產品創新。

隨著個人化醫療和先進生技藥品的持續發展，未來前景依然光明。新興市場對生物製藥生產基礎設施的投資將創造新的機會。對多功能且安全的輔料的持續研究將提高製劑效率。隨著生技藥品在製藥業中所佔佔有率的不斷擴大，生物製藥輔料市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球生物製藥輔料市場：依應用領域分類

  • 市場分析、洞察與預測
  • 注射藥物
  • 口服製劑
  • 外用製劑
  • 經皮製劑
  • 細胞和基因治療

第5章 全球生物製藥輔料市場：依類型分類

  • 市場分析、洞察與預測
  • 粘合劑
  • 崩壞
  • 潤滑劑
  • 防腐劑
  • 穩定器

第6章：全球生物製藥輔料市場：功能性

  • 市場分析、洞察與預測
  • 功能性添加劑
  • 多功能添加劑
  • 惰性輔料
  • 有效輔料

第7章 全球生物製藥輔料市場：依最終用途分類

  • 市場分析、洞察與預測
  • 製藥公司
  • 契約製造組織
  • 研究機構

第8章 全球生物製藥輔料市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和分銷通路合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • FMC Corporation
    • Weifang Huahong Technology Co. Ltd
    • Lactofarma SA
    • Sausage Technology Co. Ltd
    • Merck KGaA
    • Roquette FrAfA¨Res
    • JRS PHARMA GmbH & Co. KG
    • Ashland Global Holdings Inc
    • Dow Chemical Company
    • ProFusion Industries LLC
    • Brenntag SE
    • BASF SE
    • Shin-Etsu Chemical Co. Ltd
    • Evonik Industries AG
    • Signet Chemical Corporation Pvt. Ltd
簡介目錄
Product Code: VMR11210576

The Biopharmaceutical Excipients Market size is expected to reach USD 13.41 Billion in 2034 from USD 8.10 Billion (2025) growing at a CAGR of 5.76% during 2026-2034.

The Global Biopharmaceutical Excipients Market has grown significantly with the expansion of biologics and biosimilar drug development. Excipients play a crucial role in stabilizing, preserving, and enhancing the delivery of biopharmaceutical products. The increasing prevalence of chronic diseases and rising demand for targeted therapies have driven innovation in biologic formulations. Growing pharmaceutical research and manufacturing activities further support market growth.

Major drivers include advancements in protein-based therapeutics, increasing regulatory approvals for biologics, and demand for improved drug stability. Biopharmaceutical excipients help maintain product efficacy during storage and transportation. Expansion of vaccine development programs and monoclonal antibody production also contribute to rising demand. Collaborative efforts between pharmaceutical companies and excipient manufacturers accelerate product innovation.

Future prospects remain promising as personalized medicine and advanced biologics continue to expand. Emerging markets investing in biopharmaceutical manufacturing infrastructure will create new opportunities. Continuous research into multifunctional and safer excipients will enhance formulation efficiency. As biologics gain a larger share of the pharmaceutical industry, the biopharmaceutical excipients market is projected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Injectable Formulations
  • Oral Formulations
  • Topical Formulations
  • Transdermal Formulations
  • Cell And Gene Therapy

By Type

  • Binders
  • Disintegrants
  • Lubricants
  • Preservatives
  • Stabilizers

By Functionality

  • Functional Excipients
  • Multi-functional Excipients
  • Inert Excipients
  • Active Excipients

By End Use

  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Research Institutes

COMPANIES PROFILED

  • FMC Corporation, Weifang Huahong Technology Co Ltd, Lactofarma SA, Sausage Technology Co Ltd, Merck KGaA, Roquette Frres, JRS PHARMA GmbH Co KG, Ashland Global Holdings Inc, Dow Chemical Company, ProFusion Industries LLC, Brenntag SE, BASF SE, ShinEtsu Chemical Co Ltd, Evonik Industries AG, Signet Chemical Corporation Pvt Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Injectable Formulations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Oral Formulations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Topical Formulations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Transdermal Formulations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Cell And Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Binders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Disintegrants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Lubricants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Preservatives Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Stabilizers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Functionality
  • 6.2. Functional Excipients Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Multi-functional Excipients Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Inert Excipients Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Active Excipients Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Contract Manufacturing Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Application
    • 8.2.2 By Type
    • 8.2.3 By Functionality
    • 8.2.4 By End Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Application
    • 8.3.2 By Type
    • 8.3.3 By Functionality
    • 8.3.4 By End Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Application
    • 8.4.2 By Type
    • 8.4.3 By Functionality
    • 8.4.4 By End Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Application
    • 8.5.2 By Type
    • 8.5.3 By Functionality
    • 8.5.4 By End Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Application
    • 8.6.2 By Type
    • 8.6.3 By Functionality
    • 8.6.4 By End Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOPHARMACEUTICAL EXCIPIENTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 FMC Corporation
    • 10.2.2 Weifang Huahong Technology Co. Ltd
    • 10.2.3 Lactofarma S.A
    • 10.2.4 Sausage Technology Co. Ltd
    • 10.2.5 Merck KGaA
    • 10.2.6 Roquette FrAfA¨Res
    • 10.2.7 JRS PHARMA GmbH & Co. KG
    • 10.2.8 Ashland Global Holdings Inc
    • 10.2.9 Dow Chemical Company
    • 10.2.10 ProFusion Industries LLC
    • 10.2.11 Brenntag SE
    • 10.2.12 BASF SE
    • 10.2.13 Shin-Etsu Chemical Co. Ltd
    • 10.2.14 Evonik Industries AG
    • 10.2.15 Signet Chemical Corporation Pvt. Ltd